Sir John Bell is the second Canadian, after the distinguished Sir William Osler, to occupy the prestigious Regius Professorship of Medicine at Oxford University. He is universally recognized as one of the leading figures in translational medicine, transforming scientific discoveries into treatments by turning “biomedical molecules into medicine.” A thought leader advancing interactions between the academic sector, industry and government, Sir John has advised Prime Ministers and governments in both Britain and Canada. He helped identify genes involved in susceptibility to diabetes mellitus, rheumatoid arthritis, and multiple sclerosis, and has elucidated T cell surface interactions involved in immune activation. He has worked on biomedical applications of genomic technologies in clinical settings and helped to develop the 100,000 genome project for Genomics England. He chaired the oversight committee for developing a Coronavirus vaccine at Oxford’s Edward Jenner Institute, founded the Wellcome Trust Centre for Human Genetics, built an entire research campus at Oxford, and has championed progressive government science policy. Sir John, described as “Chief Architect of Government Strategy for Life Sciences,” has helped bridge the worlds of pure research and clinical medicine for the betterment of world health.